Month: December 2020

Collaboration brings together clinical stage SHP2 and KRAS G12C inhibitorsRelay Therapeutics will receive $75 million upfront and is eligible to receive an additional $25 million in near-term payments and $695 million in additional potential milestones,plus royalties on global net product salesRelay Therapeutics to host conference call at 8:00 a.m. ETCAMBRIDGE, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, today announced it has entered into a worldwide license and collaboration agreement with Genentech, a member of the Roche Group, for the development and commercialization of RLY-1971, a potent inhibitor of SHP2. Under the collaboration, Genentech will assume...

VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on developing organic certified and premium cannabis products, is pleased to announce the appointment of Julie Lassonde to its Board of Directors (the “Board”), subject to the receipt of Health Canada’s customary security clearance.“We are thrilled to add Julie to our Board of Directors. Julie’s significant executive experience guiding early stage growth companies through to maturity is a perfect complement to Rubicon Organics and, on behalf of the Board, we are very keen to be working with her,” said Jesse McConnell, Chief Executive Officer.Ms. Lassonde has more than 20 years of experience in the banking and mining sectors in senior executive...

VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE) — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the successful launch of its first “Film Bubble” for a major motion picture (“MMP1”) that is scheduled to commence filming in January 2021. The name of the film and the starring actors will remain confidential until the commencement of filming.The launch of the Film Bubble for MMP1 is the result of a partnership agreement with Draganfly Inc (DFLY:CSE). Draganfly’s Safe Set Solutions for the global film and TV production industry is a ground-based technology...

Analysis of 37 participants immunized with BNT162b2 showed a broad immune response with SARS-CoV-2-specific neutralizing antibodies, TH1 type CD4+ T cells, and strong expansion of CD8+ T cells of the early effector memory phenotypeAll vaccinated participants demonstrated neutralizing antibody as well as T cell responses. T cell responses were directed against multiple regions of the spike protein, including the RBD, suggesting immune recognition of multiple independent epitopesData confirm previous findings from the U.S. trial demonstrating a good safety profile and robust induction of antibody responses with a longer follow-up period of 85 daysAntibodies generated in trial subjects were able to neutralize pseudo-viruses representing 19 diverse SARS-CoV-2 variants, indicating potential for broad protection against viruses with reported...

Analyse von 37 mit BNT162b2 geimpften Probanden zeigte eine umfangreiche Immunantwort mit SARS-CoV-2-neutralisierenden Antikörpern, CD4+ T-Zellen des Typs TH1 sowie eine starke Expansion von CD8+ Gedächtnis-T-Zellen des frühen Effektor-Gedächtnis-PhänotypsAlle geimpften Probanden zeigten neutralisierende Antikörper- sowie T-Zell-Antworten; letztere richteten sich gegen mehrere verschiedene Regionen des Spike-Proteins, einschließlich der Rezeptorbindungsdomäne (RBD), was auf eine Erkennung verschiedener unabhängiger Epitope durch das Immunsystem hinweistDaten bestätigen Ergebnisse der vorangegangenen U.S.-Studie, die ein positives Sicherheitsprofil und die Induktion einer robusten Antikörper-Antwort zeigte, wobei in der deutschen Studie eine längere Beobachtungszeit von 85 Tagen analysiert wurdeDie in den Probanden generierten Antikörper...

PROGRAMME DE RACHATDECLARATION DES TRANSACTIONS SUR ACTIONS PROPRESSOCIETE FLEURY MICHONPrésentation agrégée par jour et par marchéPériode : 07/12/2020 au 11/12/2020Détail transaction par transactionPièce jointeDéclaration Transactions du 7 au 11 décembre 2020

Hong Kong, Dec. 14, 2020 (GLOBE NEWSWIRE) — HONG KONG, 14 Dec 2020 – Cyberport’s annual Digital Entertainment Leadership Forum (DELF) concluded successfully. The event generated over 100 hours of content on its virtual platform, drawing a total of 500,000 views from almost 30 countries or regions. The two-day forum was held in a virtual and interactive format for the first time and brought together more than 60 speakers to share on the topic “New Normal of Digital Entertainment: From Gamification to Esportification”, as well as staging a number of tournaments, start-up showcases and pitching contests to tap into the esports and digital entertainment craze. On the second day of the forum, Cyberport and the Association of Pacific Rim Universities (APRU) held the first Esports MetaGame Conference and announced a number of collaboration...

TORONTO, Dec. 14, 2020 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) announces that it will begin to publicly disclose unaudited net asset value per share (“NAV”) on a monthly basis, commencing with the January 31, 2021 period. This expands on ThreeD’s established practice of releasing NAV on a quarterly basis and reflect our response to shareholder interest in receiving NAV information more frequently.Monthly NAV will be disclosed by the Company in a press release and be available on the Company’s website approximately 15 days after month-end. NAV will be calculated based on unaudited month-end financial information.NAV is a non-GAAP measure calculated as the value of total assets less the value of total liabilities divided by total number of common shares outstanding, as at a specific...

Company Announcement No. 850On 29 October 2020, we initiated a share buyback programme, as described in Company Announcement No. 842 of 29 October 2020. According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 6,000,000,000 and no more than 12,000,000 shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.As at today, DSV Panalpina A/S holds a total of 3,645,853 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 1.59% of the total number of issued shares of 230,000,000.The...